Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
4
×
detroit blog main
detroit top stories
eli lilly
4
×
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
cancer immunotherapy
pfizer
takeda pharmaceutical
abbvie
aduro biotech
alexion pharmaceuticals
biogen
What
bio
roundup
drug
companies
new
pharmaceutical
price
typically
acquisitions
alzheimer’s
approval
bails
biggest
biogen’s
biopharmaceutical
brand
bridgebio
build
buy
capital
car
ceo
company’s
convo
daniel
debut
develop
different
drugs
dyne’s
earlier
emerges
fail
failures
firm
gene
gilead
grab
headlines
ichnos
Language
unset
Current search:
biotech
×
novartis
×
deals
×
national
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More